I’d buy these 2 FTSE 100 growth stocks that have soared since the stock market crash

These two fast-growing companies have just entered the FTSE 100 and continue to offer plenty of healthy income and growth prospects.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today, the FTSE 100 enjoys a fresh injection of blood as four new companies entered the index – Avast, GVC Holdings, Homeserve, and Kingfisher.

All are enjoying the attention, with their shares jumping even though the FTSE 100 index is down. The Avast (LSE: AVST) and HomeServe (LSE: HSV) share prices are up around 4%, continuing strong recent runs. They still look tempting buys to me.

Momentum on their side

Avast calls itself “the world’s leading consumer cybersecurity company,” with 20 offices worldwide, including in London and Silicon Valley. The Czech-based company floated in London two years ago at 246p. Its share price has since doubled, trading at 525p today.

Keeping people safe online is big business as the fraud threat is, unfortunately, forever. Avast’s 2016 acquisition of rival AVG turned the FTSE 100 newbie into a cybersecurity giant. It serves consumers and small businesses, and is best known for its Avast antivirus software. 

The Avast share price has momentum on its side, bouncing back sharply from the March crash. It now trades 60% higher than just three months ago.

This FTSE 100 tech play looks an attractive growth and income stock, given current momentum and the size of the market it’s pitching at. It isn’t even that expensive, trading at 19 times earnings. You also get a dividend, with the stock yielding a decent 2.3%.

The £5.4bn FTSE 100 group has almost 13m paying customers. It’s expanding into network and smart home security, and plans to grow further through targeted M&A.

Avast boasts high barriers to entry and strong competitive moats, while its subscription-based business model offers high cash and revenue visibility. The coronavirus pandemic should have little impact, as people are more dependent on their screens than ever, while fraudsters are more active.

As more established FTSE 100 names struggle, I would suggest turning your attention to the new and fast-growing kid on the block.

I’d buy this FTSE 100 stock too

Home emergency repairs company HomeServe is another FTSE 100 new entry that’s looking to accelerate growth. Its share price has also jumped 60% in just three months. Over five years, it’s up an impressive 200%. The home emergency cover specialist has also weathered the coronavirus in decent shape, as it was declared an essential service. Staff worked on throughout. No firings, no furloughs.

International expansion should drive future growth and revenue prospects. The FTSE 100 new entry already has more than 8m customers in the US, more than half of its total, and is targeting Japan next.

It’s growing fast, with sales up 10% in the year to 31 March while underlying profits rose 12% to £181m.

The £4.3bn FTSE 100 group currently yields around 2%. The one sticking point is that it is expensive, trading at around 30 times earnings. That shows just how well the HomeServe share price has done, and how highly investors rate its prospects.

You won’t find many better growth stocks on the FTSE 100 than these two right now.

Harvey Jones has no position in any of the shares mentioned. The Motley Fool UK has recommended Homeserve. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »